ALAMEDA, Calif., Nov. 20, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024.Event:     Piper Sandler 36th Annual Healthcare ConferenceDate:      Wednesday, December 4, 2024Time:      8:00am ET/5:00am PTA webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com ...

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Gro ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium also includes the Zacks Style Scores.What are the Zacks Style Scores?The Zacks Style ...

Penumbra, Inc. (PEN) reported third-quarter 2024 adjusted earnings per share (EPS) of 85 cents, which surpassed the Zacks Consensus Estimate by 23.2%. Adjusted EPS improved 26.9% year over year.GAAP earnings were 75 cents per share, a 226% jump from the year-ago GAAP earnings of 23 cents per share.Following the earnings announcement, shares of PEN rose 1.3% in after-market trading yesterday.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Q3 Revenues of PENPenumbra registered revenue ...

Penumbra, Inc. (NYSE:PEN) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Cecilia Furlong - Director of Business Development and Investor Relations Adam Elsesser - Chairman and Chief Executive Officer Maggie Yuen - Chief Financial Officer Jason Mills - Executive Vice President of Strategy Conference Call Participants Richard Newitter - Truist Securities Robert Marcus - JPMorgan Joanne Wuensch - Citi Michael Sarcone - Jefferies Samantha Kurtz - Piper Sandler Michael Kratky - ...

Penumbra (PEN) reported $301.04 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 11.1%. EPS of $0.85 for the same period compares to $0.67 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $298.09 million, representing a surprise of +0.99%. The company delivered an EPS surprise of +23.19%, with the consensus EPS estimate being $0.69. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wa ...

Penumbra (PEN) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.67 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 23.19%. A quarter ago, it was expected that this medical device maker would post earnings of $0.56 per share when it actually produced earnings of $0.64, delivering a surprise of 14.29%.Over the last four quarters, the com ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from_____ to _____ Commission File Number: 001-37557 Penumbra, Inc. (Exact name of registrant as specified in its charter) Delaware 05-0605598 (State or other ...

Exhibit 99.1 Penumbra, Inc. Reports Third Quarter 2024 Financial Results ALAMEDA, Calif., Oct. 30, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the third quarter ended September 30, 2024. 1 • Revenue of $301.0 million in the third quarter of 2024, an increase of 11.1% or 10.9% in constant currency , compared to the third quarter of 2023. • U.S. thrombectomy revenue of $162.1 million in the third quarter of 2024 increased 21.2 ...

ALAMEDA, Calif., Oct. 30, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the third quarter ended September 30, 2024. Revenue of $301.0 million in the third quarter of 2024, an increase of 11.1% or 10.9% in constant currency1, compared to the third quarter of 2023. U.S. thrombectomy revenue of $162.1 million in the third quarter of 2024 increased 21.2% and 5.4% compared to the third quarter of 2023 and second quarter of 2024, re ...